10x Genomics to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
August 31 2021 - 4:05PM
10x Genomics, Inc. (Nasdaq: TXG), today announced the company will
be participating in the Morgan Stanley 19th Annual Global
Healthcare Conference.
10x Genomics’ management is scheduled to present on Monday,
September 13th, at 2:45 p.m. Eastern Time/11:45 a.m. Pacific Time.
Interested parties may access a live and archived webcast of the
presentation on the “Investors” section of the company’s website
at: https://investors.10xgenomics.com/.
About 10x Genomics
10x Genomics is a life science technology company building
products to interrogate, understand and master biology to advance
human health. The company’s integrated solutions include
instruments, consumables and software for analyzing biological
systems at a resolution and scale that matches the complexity of
biology. 10x Genomics products have been adopted by researchers
around the world including in all of the top 100 global research
institutions as ranked by Nature in 2020 based on publications and
all of the top 20 global pharmaceutical companies by 2020 research
and development spend and have been cited in over 2,800 research
papers on discoveries ranging from oncology to immunology and
neuroscience. The company’s patent portfolio comprises more than
1,150 issued patents and patent applications.
Disclosure Information
10x Genomics uses filings with the Securities and Exchange
Commission, its website (www.10xgenomics.com), press releases,
public conference calls, public webcasts and its social media
accounts as means of disclosing material non-public information and
for complying with its disclosure obligations under Regulation
FD.
Media Contact:
media@10xgenomics.com
Investor Relations Contact:
investors@10xgenomics.com
10x Genomics (NASDAQ:TXG)
Historical Stock Chart
From Jun 2024 to Jul 2024
10x Genomics (NASDAQ:TXG)
Historical Stock Chart
From Jul 2023 to Jul 2024